LLY
82
-2
SBUX
41
2
UAL
66
-6
STT
62
-2
ADI
71
-2
HP
41
3
LNC
66
-2
AMG
80
-2
HPE
66
-2
SYF
67
-7
TSCO
49
-2
AAL
45
-3
APD
54
2
HBAN
77
-5
TXT
75
-3
COP
44
4
DUK
57
2
TMO
66
2
BDX
59
-2
WYNN
44
-2
LLY
82
-2
SBUX
41
2
UAL
66
-6
STT
62
-2
ADI
71
-2
HP
41
3
LNC
66
-2
AMG
80
-2
HPE
66
-2
SYF
67
-7
TSCO
49
-2
AAL
45
-3
APD
54
2
HBAN
77
-5
TXT
75
-3
COP
44
4
DUK
57
2
TMO
66
2
BDX
59
-2
WYNN
44
-2
Financhill
Back

Astellas Pharma, Inc. 10K Form

Buy
82

ALPMF
Astellas Pharma, Inc.

Last Price:
$13.17
Seasonality Move:
0.16%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ALPMF News And Ratings

See the #1 stock for the next 7 days that we like better than ALPMF

ALPMF Financial Statistics

Sales & Book Value

Annual Sales: $12.5B
Cash Flow: $1.3B
Price / Cash Flow: 11.18
Annual Sales: $6.10
Price / Book: 2.33

Profitability

EPS (TTM): 0.47840
Net Income (TTM): $861.2M
Gross Margin: $9.4B
Return on Equity: 8.36%
Return on Assets: 3.75%

Astellas Pharma, Inc. Earnings Forecast

Key Astellas Pharma, Inc. Financial Ratios

  • The Gross Profit Margin over the past 45 years for ALPMF is 74.59%.
  • The Selling, General & Administrative Expenses for ALPMF have been equal to 44.08% of Gross Profit Margin.
  • The Research & Development expenses have been 17.13% of Revenue.
  • The Interest Expense is 28.28% of Operating Income.
  • The Net Earning history of ALPMF is 2.65% of Total Revenues.
  • Per Share Earnings over the last 45 years have been positive in 26 years.

Astellas Pharma, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: ALPMF
Website: astellas.com

Debt

Debt-to-Equity Ratio: 0.46
Current Ratio: 1.03
Quick Ratio: 0.75

Price-to-Earnings

Trailing P/E Ratio: 76.67
Forward P/E Ratio: 0

ALPMF Technical Analysis vs Fundamental Analysis

Buy
82
Astellas Pharma, Inc. (ALPMF) is a Buy

Is Astellas Pharma, Inc. a Buy or a Sell?